CEG

At the October 26 close of $252.48, CEG trades at 24.68x trailing earnings, 18.97x forward earnings on FY27 consensus EPS of $13.35429 (20.82x on FY26 EPS of $12.12544), 14.36x EV/EBITDA, 2.86x price-to-sales and 2.81x price-to-book on an $89.46 billion market capitalization and a $114.15 billion enterprise value, which is 1.28x market cap and reflects the net debt load. The forward multiple has compressed from 21.61x at the September 28 close cited in the Zacks article, largely because price has fallen rather than because estimates have been cut. The favorable read is that FY26 growth of 29.82% against 20.82x produces an arithmetic PEG near 0.70x, and the September 28 Zacks piece cited a 1.45 PEG versus 2.2 for its industry. The less favorable read is that FY27 growth decelerates sharply, with current consensus of $13.35429 against $12.12544 implying about 10.1% (Zacks published 8.76%), so 18.97x divided by roughly 10% yields a PEG near 1.9x, and the stock still screens at a premium to the roughly 19.5x electric-utility average and the 17.61x industry multiple. The supplied derived PEG of -0.53 is mechanically meaningless because it divides the forward multiple by the negative GAAP earnings growth of -46.8% and should be ignored. Simply Wall St argued the fundamentals-implied fair multiple sits above the current price, but that conclusion depends on contracted nuclear expansion and relicensing executing on schedule. Net assessment: fairly valued at best relative to current cash generation and only attractive if the 2030-2032 capacity arrives on budget; the $339.16 mean target implies 34.3% upside and the $399 high implies 58.0%, but the $238 low target sits only 5.7% below spot, so the published downside cushion is thin.

CEG closed at $252.48 on October 26, down 0.38% from $253.45, printing a new closing low for the October sequence while the intraday low of $249.20 held roughly $2 above the $247.20 September 30 swing low. The trend structure remains unambiguously bearish: price sits 7.44% below the SMA20 at $272.76, 6.91% below the EMA50 at $271.22 and 13.12% below the EMA200 at $290.61, while the EMA50 remains 6.67% below the EMA200, so death-cross alignment is intact and has widened from 6.59% the prior session. The October 26 range of $255.62-$249.20 was 6.42 points, or 0.50x the $12.73 ATR, and the close finished 51.1% up the range. The sequence of lower highs remains fully intact at $309.80 (October 6), $306.99 (October 8), $298.50 (October 13), $294.50 (October 14), $277.21 (October 19), $273.21 (October 21), $269.02 (October 22), $256.79 (October 23) and $255.62 (October 26); a reclaim of $272.76 is the first requirement to stabilize and $290.61 is required to restore the bullish case, while a close below $247.20 reopens $238 and eventually the $228.63 52-week low. The stock is 37.82% below its 52-week high and sits at just 13.44% of its 52-week range.

Q2 2026 adjusted EPS of $2.55 beat the $2.28235 consensus by 11.73% and was up 33.5% year over year versus $1.91, though it fell 6.9% sequentially from $2.74; management raised FY26 guidance alongside the September 30 nuclear agreements, and the six supplied quarters average a +3.0% surprise with two misses (Q3 2025 at -2.57% and Q1 2025 at -3.10%). For the November 9 print the baseline itself is ambiguous: the estimate series now lists current-quarter EPS of $3.79365 (implying about +24.8% versus the $3.04 reported in Q3 2025), while the September 28 Zacks article cites roughly $3.99 (+31.25% year over year) and $8.65 billion of revenue, a roughly 5.2% gap that should be verified rather than treated as a precise hurdle, and Q3 2025 was itself a 2.57% miss.

The September 30 Amazon 20-year agreement remains the single most consequential structural item because it converts the data-center power narrative into a contracted 690 MW revenue stream over two decades, justifies more than $3 billion of Calvert Cliffs investment and creates the commercial foundation for a further 20-year operating license. For the immediate window, however, the highest-impact item is the November 9 earnings print only 13 days away: sell-side support has been exhausted as a trading catalyst after the market rejected Morgan Stanley's October 21 raise and HSBC's October 22 Buy initiation, and the stock failed to rally even on a day when the S&P 500 gained 0.70% and VIX fell 5.45%.

VIX fell 5.45% to 18.39 and the S&P 500 gained 0.70%, yet CEG still closed 0.38% lower, so this high-beta, capital-intensive AI-power proxy is now underperforming an improving tape and remains exposed to the still-elevated 4.986% 10-year yield.

Constellation Energy is not a defensive regulated utility. The nuclear fleet plus Amazon's 20-year, 690 MW commitment create genuine long-dated demand, but the company carries $24.70 billion of debt against $697 million of cash, generated negative $6.63 billion of free cash flow on $4.21 billion of operating cash flow, and funds roughly $10.83 billion of implied capex at about 2.6x operating cash flow. The 1.129 beta badly understates the equity's behavior: 20-day realized volatility is 65.04% and ATR is 5.04% of price, so 5-8% two-day swings are routine. The October 26 close of $252.48 is 13.12% below the EMA200 and 37.82% below the 52-week high, and the stock is only 13.44% up its 52-week range. It belongs in a deliberately sized satellite sleeve rather than as a core anchor, with medium thesis durability reflecting a nuclear growth path that is real but financing-dependent and back-end loaded to 2030-2032.